Satellos Bioscience Inc.
MSCL
Rank in Stocks
#17775
Satellos Bioscience Inc., a biotechnology firm established in 2018 and... Satellos Bioscience Inc., a biotechnology firm established in 2018 and headquartered in Toronto, Canada, specializes in developing regenerative therapies for degenerative muscle diseases. The company primarily operates in Canada and Australia, utilizing its proprietary MyoReGenX platform – an automated microscopy system engineered to replicate the muscle stem cell environment outside the body. A key focus for Satellos is the discovery and development of a small molecule drug specifically aimed at treating Duchenne muscular dystrophy.
Share Price
$10.22
Last synced: 2026-07-31
Market Cap
$212.97M
Change (1 day)
4.58%
Change (1 year)
2,278.10%
Country
CA
Trade Satellos Bioscience Inc. (MSCL)
Category
Healthcare
Stock price history for Satellos Bioscience Inc. (MSCL)
Highest end of day price: $0.48 on 2024-03-01
Lowest end of day price: $12.71 on 2008-01-01
Lowest end of day price: $12.71 on 2008-01-01
Stock price history of Satellos Bioscience Inc. from 2008 to 2026
Annual Stock Price Performance
| Year | Performance |
|---|---|
| 2024 | 43.42% |
| 2023 | 91.27% |
| 2022 | -80.10% |
| 2021 | 2.79% |
| 2020 | -11.41% |
| 2019 | 10.94% |
| 2018 | 37.66% |
| 2017 | -27.41% |
| 2016 | 41.02% |
| 2015 | -8.55% |
| 2014 | -90.26% |
| 2013 | -52.35% |
| 2012 | 195.82% |
| 2011 | -36.68% |
| 2010 | -30.40% |
| 2009 | 333.63% |
| 2008 | 0.00% |
Stock price for similar companies or competitors
| Company | Stock price | Change 1y% | Country |
|---|---|---|---|
| $518.71 | 21.68% |
US
|
|
| $247.50 | 800.33% |
US
|
|
| $138.33 | -3.31% |
AU
|
|
| $886.30 | 6.17% |
NL
|
|
| $752.87 | 7.40% |
CH
|
